CHART OF SEPTEMBER 2014
Evolution of the share of multiple-source statin prescriptions among all statin prescriptions between 2002 and 2011, France
Sources: Data IMS Health / Permanent Survey on Medical Prescriptions
Calculation and realisation: IRDES
Reading: prescription rates for statins increase within the group of approved multiple-source drugs when a new multiple source molecule is introduced. Since 2006, trends regarding prescriptions of multiple-source statins are rather on the decline, which is perhaps why such prescriptions were backed up by a support policy. Moreover, they also constitute one goal listed in the measure “Remuneration based on public health goals” (Rémunération sur objectif de santé publique, ROSP).
All the charts...
September 5th, 2014